Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessResearch

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

Daria Handkiewicz-Junak1,2 email, Jozef Roskosz1,2 email, Kornelia Hasse-Lazar1,2 email, Sylwia Szpak-Ulczok1,2 email, Zbigniew Puch1,2 email, Aleksandra Kukulska1,2 email, Tomasz Olczyk1,2 email, Andrzej Piela3 email, Ewa Paliczka-Cieslik1,2 email and Barbara Jarzab1,2 email

Department of Nuclear Medicine, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland

Department of Endocrine Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland

Department of Surgical Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland

author email corresponding author email

Thyroid Research 2009, 2:8doi:10.1186/1756-6614-2-8

Published: 1 August 2009

Additional files

Additional file 1:

Thyroglobulin before and after 13-CRA RDT. The data provided represent thyroglobulin concentration (ng/ml) before and after redifferentiation therapy in all 53 treated patients.

Format: DOC Size: 100KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.